🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/10/2019 | 66,86 | 68,09 | 66,48 | 67,73 | +2,49% | 2,41% | 451.565 |
| 18/10/2019 | 67,07 | 67,46 | 64,89 | 66,08 | -2,08% | 3,83% | 364.522 |
| 17/10/2019 | 66,96 | 68,47 | 66,21 | 67,49 | +1,60% | 3,36% | 320.440 |
| 16/10/2019 | 67,18 | 68,42 | 66,39 | 66,43 | -1,23% | 3,02% | 417.742 |
| 15/10/2019 | 65,50 | 67,34 | 64,69 | 67,26 | +2,96% | 4,04% | 363.721 |
| 14/10/2019 | 65,32 | 65,90 | 64,14 | 65,32 | -0,79% | 2,69% | 258.243 |
| 11/10/2019 | 65,20 | 66,65 | 64,37 | 65,84 | +2,67% | 3,49% | 515.845 |
| 10/10/2019 | 63,54 | 64,82 | 63,14 | 64,13 | +1,54% | 2,63% | 253.114 |
| 09/10/2019 | 62,81 | 63,72 | 62,51 | 63,16 | +1,15% | 1,92% | 261.930 |
| 08/10/2019 | 64,97 | 64,97 | 61,89 | 62,44 | -3,58% | 4,74% | 451.886 |
| 07/10/2019 | 63,71 | 65,92 | 63,51 | 64,76 | +1,72% | 3,79% | 489.877 |
| 04/10/2019 | 63,74 | 64,49 | 61,76 | 63,66 | +0,23% | 4,28% | 345.126 |
| 03/10/2019 | 60,53 | 64,06 | 59,86 | 63,52 | +5,03% | 6,94% | 681.435 |
| 02/10/2019 | 60,14 | 61,01 | 58,75 | 60,47 | -0,47% | 3,75% | 572.111 |
| 01/10/2019 | 62,74 | 62,97 | 60,42 | 60,76 | -2,15% | 4,06% | 542.616 |
| 30/09/2019 | 62,08 | 62,58 | 61,35 | 62,10 | +0,60% | 1,98% | 406.040 |
| 27/09/2019 | 61,51 | 62,51 | 60,65 | 61,73 | +0,39% | 3,03% | 453.008 |
| 26/09/2019 | 62,63 | 62,94 | 60,66 | 61,49 | -1,84% | 3,66% | 504.144 |
| 25/09/2019 | 62,23 | 63,87 | 61,92 | 62,65 | +0,43% | 3,14% | 571.950 |
| 24/09/2019 | 65,68 | 66,29 | 62,11 | 62,38 | -4,74% | 6,35% | 1.132.680 |
| 23/09/2019 | 64,97 | 66,24 | 64,26 | 65,48 | +0,92% | 3,04% | 644.246 |
| 20/09/2019 | 65,32 | 67,17 | 64,31 | 64,88 | -0,66% | 4,37% | 1.539.040 |
| 19/09/2019 | 64,14 | 66,31 | 61,90 | 65,31 | +5,46% | 6,89% | 1.318.468 |
| 18/09/2019 | 61,80 | 62,22 | 60,42 | 61,93 | +0,30% | 2,92% | 478.015 |
| 17/09/2019 | 63,16 | 63,32 | 59,25 | 61,74 | -2,85% | 6,45% | 826.347 |
| 16/09/2019 | 60,44 | 64,07 | 58,49 | 63,55 | +4,55% | 9,23% | 1.150.794 |
| 13/09/2019 | 60,85 | 64,19 | 60,55 | 60,79 | -0,11% | 5,98% | 1.332.093 |
| 12/09/2019 | 58,20 | 62,25 | 57,70 | 60,85 | +6,26% | 7,81% | 2.116.441 |
| 11/09/2019 | 56,17 | 57,62 | 55,88 | 57,27 | +1,79% | 3,11% | 836.285 |
| 10/09/2019 | 53,69 | 56,38 | 52,68 | 56,26 | +4,57% | 6,89% | 990.013 |